Skip to main content

Table 2 Regulatory factors regulating autophagy and tumor behaviors

From: Crosstalk between autophagy and microbiota in cancer progression

Regulatory factors

ATGs

Stage of autophagy

Cancer type

Tumor promotion

/Tumor suppression

Tumor Behavior

Molecular mechanism

Ref.

TRPM3

ULK1

LC3

Induce autophagy initiation and maturation

Clear cell renal cell carcinoma

Tumor promotion

Proliferation

TRPM3 promotes autophagy through miR-214 and CAMKK2-ULK1 cascade, thus supports the ccRCC cell growth.

[76]

TRIM59

Beclin-1

induce autophagy nucleation

Non-small cell lung cancer

Tumor promotion

Tumor progression

TRIM59 promotes the transcription and the ubiquitination of BECN1 to facilitate tumor progression.

[77]

POX

Beclin-1

LC3

Induce autophagy nucleation and maturation

Colorectal cancer

Tumor promotion

Tumor survival

POX induces autophagy activation and promotes tumor cell survival in hypoxic TME.

[78]

CK1α

ATG7

Induce autophagy maturation

Lung tumor

Tumor suppression

Proliferation

CK1α activates PTEN/AKT/FOXO3a/ ATG7 axis to induce autophagy and suppress lung tumor growth.

[79]

IFN-γ

LC3

Induce autophagy maturation

Hepatocellular carcinoma

Tumor suppression

Proliferation

IFN-γ induces autophagy through IRF-1 to inhibit tumor growth.

[80]

IFN-γ

Beclin-1

Induce autophagy nucleation

Gastric cancer

Tumor suppression

Tumorigenesis

IFN-γ induces autophagy through upregulation of Beclin-1 for inhibiting tumorigenesis.

[81]

HOTAIR

Beclin-1

LC3

Inhibit autophagic activity

Cervical cancer

Tumor promotion

EMT process and radioresistance

HOTAIR attenuates sensitivity to radiotherapy by reduction of autophagy and reversal of EMT via Wnt signaling.

[82]

CTA

LC3

p62

Inhibit autophagy maturation

Osteosarcoma

Tumor suppression

Apoptosis and chemoresistance

CTA promotes apoptosis and reduces chemoresistance via downregulating BNIP3/BNIP3L and autophagy.

[83]

miR-93

Beclin-1

ATG4B

ATG5

Inhibit autophagy nucleation and maturation

Glioblastoma

Tumor promotion

Chemoresistance

miRNA-93 inhibits multiple autophagy protein and reduces chemoresistance in GSCs.

[84]

miR-18a*

miR-4802

ATG7

ULK1

Inhibit autophagy initiation and maturation

Colorectal cancer

Tumor promotion

Chemoresistance

Selective loss of miR-18a*/4802 activates cancer autophagy and enhances CRC chemoresistance.

[36]

FXYD6

Beclin-1

LC3

p62

Inhibit autophagy nucleation and maturation

Colorectal cancer

Tumor suppression

Chemoresistance

FXYD6 regulates cell autophagy via ATP-α1 activity and decreases chemotherapy resistance.

[85]

IRF1

Beclin-1

ATG7

Inhibit autophagy nucleation and maturation

Breast cancer

Tumor suppression

Chemoresistance

IRF1 inhibits the formation of autophagic vacuole and BECN1 expression to restore drug sensitivity to ICI.

[86]

HMGB1

LC3

p62

Induce autophagy maturation

Leukemia

Tumor promotion

Chemoresistance

HMGB1 induces autophagy through the PI3K/MEK/ERK pathway, thus promotes chemotherapy resistance.

[87]

  1. TRPM3 transient receptor potential melastatin-3, ULK1 unc-51-like kinase 1, LC3A light chain 3A, LC3B light chain 3B, CAMKK2 calcium-calmodulin-dependent protein kinase kinase-2, TRIM59 tripartite motif 59, BECN1 Beclin1, POX Proline Oxidase, CK1α casein kinase 1 α, ATG7 autophagy related 7, IFN-γ interferon γ, IRF1 interferon regulatory factor 1, EMT epithelial-mesenchymal transition, DOX doxorubicin, BNIP3 Bcl-2-interacting protein 3, BNIP3L BCL-2-interacting protein 3 like, ATG4B autophagy related 4B, ATG5 autophagy related 5, GSC glioblastoma cell, FXYD6 FXYD domain containing ion transport regulator 6, ICI immune checkpoint inhibitors, HMGB1 high mobility group box-1